From the economic point of view, the harm of substandard or counterfeit drugs depends on whether consumers can tell drug quality from direct or indirect information. If poor-quality drugs can always pretend to be of high quality, consumers are deceived and manufacturers are discouraged to produce high-quality in the long run.

Just when it looked like the job market was going to rebound, recent unemployment numbers revealed a disappointing reality.

“Americans spend too much on health care.” “We have worse health outcomes than our European counterparts.” Talking points such as these helped drive President Obama’s controversial and sweeping health care reform into law two years ago. But are they accurate?

Who really pays for costs of employee health benefits that rise faster than labor productivity?

In the latest Financial Services Outlook, American Enterprise Institute (AEI) housing experts Peter Wallison and Edward Pinto explain how decades of government intervention have gravely harmed America's housing market.

The general economic "health" of the U.S. manufacturing sector has re-emerged in a Presidential election year. In his 2012 State of the Union address, President Obama announced to Americans "that we have a huge opportunity, at this moment to bring manufacturing back," promising manufacturers special tax reductions and other federal...

Most people agree that the U. S. health care system, which includes Medicare, Medicaid, and private health insurance, needs to be reformed. The difficulty has been in obtaining a consensus as to the direction of the reform. Are there basic economic principles that can guide us to a better and...

At this forum, distinguished constitutional law scholars and health policy researchers will examine what we have learned thus far from the appellate litigation challenging the Affordable Care Act of 2010.